Acute organic brain syndrome from nadolol therapy.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000009:adverse effects*; D019966:Substance-Related Disorders
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol